TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 187 filers reported holding TG THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,982,000 | -34.0% | 701,690 | +47.7% | 0.02% | -17.4% |
| Q1 2022 | $4,519,000 | -48.4% | 475,190 | +5.0% | 0.02% | -39.5% |
| Q4 2021 | $8,753,000 | -42.6% | 452,353 | -1.3% | 0.04% | -44.9% |
| Q3 2021 | $15,247,000 | -53.2% | 458,146 | -45.4% | 0.07% | -50.7% |
| Q2 2021 | $32,554,000 | -20.0% | 839,254 | +0.9% | 0.14% | -22.2% |
| Q1 2021 | $40,712,000 | -42.3% | 831,547 | -38.7% | 0.18% | -54.8% |
| Q4 2020 | $70,532,000 | +82.3% | 1,355,852 | -8.3% | 0.40% | +100.0% |
| Q3 2020 | $38,698,000 | +44.1% | 1,478,729 | +2.3% | 0.20% | +30.1% |
| Q2 2020 | $26,849,000 | – | 1,445,052 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |